Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Enzalutamide in the Treatment of Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network, Astellas
    Review Process: Expert Review Panel
    Research Oncology USA
    Addressing Primary Immunodeficiencies within Minority/Underserved Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant Program
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases
    Release Date:
    Partner: The Japan College of Rheumatology
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative Disease
    Release Date:
    Partner: IHI
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Establishment of Support System for Healthy Life Extension of Patients with CV disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Racial and Ethnic Disparities in the Menopause Experience
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Immunotherapy in Urothelial Carcinoma
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology All
    Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASH
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All